List of Tables
Summary Table: Global Market for Cell Lines and Membranes, by Region, Through 2030
Table 1: Key Sources and Description of Biological Contamination of Cell Lines and Membranes
Table 2: Key Mammalian and Insect Cell Cultures
Table 3: Animal Cell Lines Used in Research
Table 4: Cell Lines in the Drug Development Process, by Application
Table 5: Top 15 Biopharmaceutical Companies, by Research and Development Spending, 2023 and 2024
Table 6: Therapeutic Area Distribution of Approved Antibody Drugs, Through October 2023
Table 7: Global Market for Cell Lines and Membranes, by Product, Through 2030
Table 8: Global Market for Cell Lines, by Region, Through 2030
Table 9: NCI-60 Cancer Cell Lines
Table 10: U.S. Cancer Research Grants, by Cancer Type, as of February 2025
Table 11: Global Market for Cancer Cell Lines, by Region, Through 2030
Table 12: Global Market for Immunotherapy Cell Lines, by Region, Through 2030
Table 13: Global Market for Ion Channel Cell Lines, by Region, Through 2030
Table 14: Global Market for Cell Signaling Pathway Cell Lines, by Region, Through 2030
Table 15: Global Market for GPCR Cell Lines, by Region, Through 2030
Table 16: Global Market for Gene Knockout Cell Lines, by Region, Through 2030
Table 17: Global Market for Other Cell Lines, by Region, Through 2030
Table 18: Global Market for Cell Membranes, by Region, Through 2030
Table 19: Global Market for Cell Lines, by Source, Through 2030
Table 20: Global Market for Mammalian Cell Lines, by Region, Through 2030
Table 21: Global Market for Non-Mammalian Cell Lines, by Region, Through 2030
Table 22: Global Market for Cell Lines and Membranes, by Application, Through 2030
Table 23: Global Cell Line and Membrane Market for Basic Research, by Region, Through 2030
Table 24: Therapeutic Area Distribution of Approved Antibody Drugs, Through October 2023
Table 25: Comparison of Human Cell Lines with Other Expression Systems in the Production of Therapeutic Proteins
Table 26: Global Cell Line and Membrane Market for Biopharmaceutical Production, by Region, Through 2030
Table 27: Global Cell Line and Membrane Market for Drug Discovery, by Region, Through 2030
Table 28: Global Cell Line and Membrane Market for Toxicity Testing, by Region, Through 2030
Table 29: Cell Lines Used in Tissue Engineering
Table 30: Global Cell Line and Membrane Market for Tissue Engineering, by Region, Through 2030
Table 31: Global Cell Line and Membrane Market for Other Applications, by Region, Through 2030
Table 32: Global Market for Cell Lines and Membranes, by End User, Through 2030
Table 33: Cell Lines Used in the Production of Biopharmaceuticals
Table 34: Global Cell Line and Membrane Market for Biotechnology and Pharmaceutical Companies, by Region, Through 2030
Table 35: Global Cell Line and Membrane Market for Academic Research and Institutes, by Region, Through 2030
Table 36: Global Cell Line and Membrane Market for Other End Users, by Region, Through 2030
Table 37: Global Market for Cell Lines and Membranes, by Region, Through 2030
Table 38: North American Market for Cell Lines and Membranes, by Product, Through 2030
Table 39: North American Market for Cell Lines and Membranes, by Type, Through 2030
Table 40: North American Market for Cell Lines and Membranes, by Source, Through 2030
Table 41: North American Market for Cell Lines and Membranes, by Application, Through 2030
Table 42: North American Market for Cell Lines and Membranes, by End User, Through 2030
Table 43: North American Market for Cell Lines and Membranes, by Country, Through 2030
Table 44: Estimated Incidence of Cancer Cases in the EU-27, by Country, 2022
Table 45: E.U. Therapeutic Monoclonal Antibodies Approved or in Review, 2023 and 2024
Table 46: European Market for Cell Lines and Membranes, by Product, Through 2030
Table 47: European Market for Cell Lines and Membranes, by Type, Through 2030
Table 48: European Market for Cell Lines and Membranes, by Source, Through 2030
Table 49: European Market for Cell Lines and Membranes, by Application, Through 2030
Table 50: European Market for Cell Lines and Membranes, by End User, Through 2030
Table 51: European Market for Cell Lines and Membranes, by Country, Through 2030
Table 52: Asia-Pacific Market for Cell Lines and Membranes, by Product, Through 2030
Table 53: Asia-Pacific Market for Cell Lines and Membranes, by Type, Through 2030
Table 54: Asia-Pacific Market for Cell Lines and Membranes, by Source, Through 2030
Table 55: Asia-Pacific Market for Cell Lines and Membranes, by Application, Through 2030
Table 56: Asia-Pacific Market for Cell Lines and Membranes, by End User, Through 2030
Table 57: Asia-Pacific Market for Cell Lines and Membranes, by Country, Through 2030
Table 58: RoW Market for Cell Lines and Membranes, by Product, Through 2030
Table 59: RoW Market for Cell Lines and Membranes, by Type, Through 2030
Table 60: RoW Market for Cell Lines and Membranes, by Source, Through 2030
Table 61: RoW Market for Cell Lines and Membranes, by Application, Through 2030
Table 62: RoW Market for Cell Lines and Membranes, by End User, Through 2030
Table 63: RoW Market for Cell Lines and Membranes, by Sub-Region, Through 2030
Table 64: Top Players Ranking in the Global Cell Line and Membrane Market, 2024
Table 65: Agreements, Collaborations and Partnerships in the Cell Line and Membrane Market, 2023-2025
Table 66: New Product Launches in the Cell Line and Membrane Market, 2023 and 2024
Table 67: Mergers and Acquisitions in the Cell Line and Membrane Market, 2023-2025
Table 68: Expansion Strategies in the Cell Line and Membrane Market, 2022?2025
Table 69: Other Competitive Strategies in the Cell Line and Membrane Market, 2022-2024
Table 70: Key Focus Areas in ESG Metrics
Table 71: ESG Rankings for Major Cell Line and Membrane Companies, as of December 2024
Table 72: ESG: Environmental Overview
Table 73: ESG: Social Factors Overview
Table 74: ESG: Governance Overview
Table 75: Abbreviations Used in this Report
Table 76: AGC Biologics: Company Snapshot
Table 77: AGC Biologics: Product Portfolio
Table 78: AGC Biologics: News/Key Developments, 2023 and 2024
Table 79: ATCC: Company Snapshot
Table 80: ATCC: Product Portfolio
Table 81: ATCC: News/Key Developments, 2023 and 2024
Table 82: Catalent Inc.: Company Snapshot
Table 83: Catalent Inc.: Financial Performance, FY 2022 and 2023
Table 84: Catalent Inc.: Product Portfolio
Table 85: Catalent Inc.: News/Key Developments, 2024 and 2025
Table 86: Cell Biolabs Inc.: Company Snapshot
Table 87: Cell Biolabs Inc.: Product Portfolio
Table 88: Creative Biolabs: Company Snapshot
Table 89: Creative Biolabs: Product Portfolio
Table 90: Creative Biolabs: News/Key Developments, 2025
Table 91: Crown Bioscience: Company Snapshot
Table 92: Crown Bioscience: Product Portfolio
Table 93: Crown Bioscience: News/Key Developments, 2024 and 2025
Table 94: Fujifilm Cellular Dynamics Inc.: Company Snapshot
Table 95: Fujifilm Cellular Dynamics Inc.: Product Portfolio
Table 96: Fujifilm Cellular Dynamics Inc.: News/Key Developments, 2022-2024
Table 97: iXCells Biotechnologies: Company Snapshot
Table 98: iXCells Biotechnologies: Product Portfolio
Table 99: iXCells Biotechnologies: News/Key Developments, 2024
Table 100: KBI Biopharma: Company Snapshot
Table 101: KBI Biopharma: Product Portfolio
Table 102: KBI Biopharma: News/Key Developments, 2022 and 2023
Table 103: Lonza: Company Snapshot
Table 104: Lonza: Financial Performance, FY 2023 and 2024
Table 105: Lonza: Product Portfolio
Table 106: Lonza: News/Key Developments, 2023
Table 107: Miltenyi Biotec: Company Snapshot
Table 108: Miltenyi Biotec: Product Portfolio
Table 109: Miltenyi Biotec: News/Key Developments, 2023 and 2024
Table 110: Promega Corp.: Company Snapshot
Table 111: Promega Corp.: Product Portfolio
Table 112: Promega Corp.: News/Key Developments, 2023 and 2024
Table 113: PromoCell GmbH: Company Snapshot
Table 114: PromoCell GmbH.: Product Portfolio
Table 115: ProBioGen AG: Company Snapshot
Table 116: ProBioGen AG: Product Portfolio
Table 117: ProBioGen AG: News/Key Developments, 2023-2025
Table 118: Thermo Fisher Scientific Inc.: Company Snapshot
Table 119: Thermo Fisher Scientific Inc.: Financial Performance, FY 2023 and 2024
Table 120: Thermo Fisher Scientific Inc.: Product Portfolio
List of Figures
Summary Figure: Global Cell Line and Membrane Market Shares, by Region, 2024
Figure 1: Cell Line Selection Characteristics
Figure 2: Supply Chain of the Cell Line and Membrane Market
Figure 3: Cell Line Development Flow Chart
Figure 4: Porter’s Five Forces Analysis: Cell Line and Membrane Market
Figure 5: PESTEL Analysis: Cell Line and Membrane Market
Figure 6: Strategic Recommendations: Cell Line and Membrane Market
Figure 7: Market Dynamics of Cell Line and Membrane
Figure 8: Emerging Technologies in the Cell Line and Membrane Market
Figure 9: Global Cell Line and Membrane Market Shares, by Product, 2024
Figure 10: Global Cell Line Market Shares, by Product, 2024
Figure 11: Process of Growing Cell Lines and Delivering to Patients
Figure 12: Production Process of Ion Channel Cell Line
Figure 13: Cell Signaling Pathway Cell Lines, by Application
Figure 14: GPCR Cell Line Development Process
Figure 15: Gene Knockout Cell Line Development Process
Figure 16: Global Cell Membrane Market Shares, by Region, 2024
Figure 17: Global Cell Line Market Shares, by Source, 2024
Figure 18: Global Cell Line and Membrane Market Shares, by Application, 2024
Figure 19: Cell Line and Membrane in Drug Discovery and Development Process, by Application
Figure 20: Global Cell Line and Membrane Market Shares, by End User, 2024
Figure 21: Biopharmaceutical Production Using Mammalian Cells
Figure 22: Cell Lines and Membranes Application in Academic and Research Institutes
Figure 23: Global Market Shares of Cell Line and Membrane, by Region, 2024
Figure 24: North American Market Shares of Cell Lines and Membranes, by Country, 2024
Figure 25: U.S. Elderly* Population, 2010-2050
Figure 26: European Market Shares of Cell Lines and Membranes, by Country, 2024
Figure 27: Asia-Pacific Market Shares of Cell Lines and Membranes, by Country, 2024
Figure 28: RoW Market Shares of Cell Lines and Membranes, by Sub-Region, 2024
Figure 29: Catalent Inc.: Revenue Share, by Business Unit, FY 2023
Figure 30: Catalent Inc.: Revenue Share, by Region/Country, FY 2023
Figure 31: Lonza: Revenue Share, by Business Unit, FY 2024
Figure 32: Thermo Fisher Scientific Inc.: Revenue Share, by Business Unit, FY 2024
Figure 33: Thermo Fisher Scientific Inc.: Revenue Share, by Country/Region, FY 2024
